Actual and future strategies for transplantation in atypical HUS associated with mutations in factor H.
作者信息
Riedl Magdalena, Rosales Alejandra, Zimmerhackl Lothar Bernd, Jungraithmayr Therese
出版信息
Pediatr Transplant. 2011 May;15(3):225-8. doi: 10.1111/j.1399-3046.2010.01345.x.
Abstract
摘要
相似文献
1
Actual and future strategies for transplantation in atypical HUS associated with mutations in factor H.与补体因子H突变相关的非典型溶血尿毒综合征的当前及未来移植策略
Pediatr Transplant. 2011 May;15(3):225-8. doi: 10.1111/j.1399-3046.2010.01345.x.
2
Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.非典型溶血性尿毒症综合征肾移植后的预防性依库珠单抗治疗
N Engl J Med. 2010 May 6;362(18):1746-8. doi: 10.1056/NEJMc1001060.
3
Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.肝肾移植治疗非典型溶血性尿毒症综合征。
J Am Soc Nephrol. 2009 May;20(5):940-9. doi: 10.1681/ASN.2008080906. Epub 2008 Dec 17.
4
Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.在第三次肾移植治疗伴 CFH 突变的非典型溶血尿毒症综合征后，使用依库珠单抗治疗并停止血浆置换以维持肾功能。
Am J Kidney Dis. 2010 Apr;55(4):708-11. doi: 10.1053/j.ajkd.2009.08.011. Epub 2009 Oct 25.
5
A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.伴有H因子突变的非典型溶血性尿毒症综合征患者肾移植3年预后良好：病例报告
Transplant Proc. 2010 May;42(4):1352-4. doi: 10.1016/j.transproceed.2010.03.048.
6
Eculizumab for atypical hemolytic-uremic syndrome.依库珠单抗用于非典型溶血性尿毒症综合征
N Engl J Med. 2009 Jan 29;360(5):542-4. doi: 10.1056/NEJMc0808527.
7
New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab.用补体抑制剂依库珠单抗治疗非典型溶血尿毒综合征的新选择。
Semin Thromb Hemost. 2010 Sep;36(6):669-72. doi: 10.1055/s-0030-1262889. Epub 2010 Sep 23.
8
Changing strategies for organ transplantation in atypical haemolytic uraemic syndrome: a tertiary case series.非典型溶血性尿毒症综合征器官移植策略的改变：一项三级病例系列研究
Pediatr Transplant. 2013 May;17(3):E93-9. doi: 10.1111/petr.12066. Epub 2013 Mar 6.
9
Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.补体突变对非典型溶血尿毒综合征临床特征的差异影响。
J Am Soc Nephrol. 2007 Aug;18(8):2392-400. doi: 10.1681/ASN.2006080811. Epub 2007 Jun 28.
10
Liver-kidney transplantation to cure atypical HUS: still an option post-eculizumab?肝肾移植治疗非典型溶血尿毒综合征：在使用依库珠单抗后仍是一种选择吗？
Pediatr Nephrol. 2014 Mar;29(3):329-32. doi: 10.1007/s00467-013-2722-2. Epub 2013 Dec 22.
引用本文的文献
1
Membrano-proliferative glomerulonephritis, atypical hemolytic uremic syndrome, and a new complement factor H mutation: report of a case.膜增生性肾小球肾炎、非典型溶血尿毒症综合征和一种新的补体因子 H 突变：病例报告。
Pediatr Nephrol. 2012 Oct;27(10):1995-9. doi: 10.1007/s00467-012-2210-0. Epub 2012 Jun 5.
Zotero 插件